Advanced Medical Solutions Group (LON:AMS) Stock Price Down 25.4% – Should You Sell?

Advanced Medical Solutions Group plc (LON:AMS)’s share price fell 25.4% on Monday . The company traded as low as GBX 187 and last traded at GBX 191.27. 48,315,629 shares changed hands during trading, an increase of 2,269% from the average session volume of 2,039,652 shares. The stock had previously closed at GBX 256.26.

Analysts Set New Price Targets

A number of brokerages have recently commented on AMS. Berenberg Bank reaffirmed a “buy” rating and set a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 260 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The stock’s 50-day moving average price is GBX 218.60 and its 200 day moving average price is GBX 216.48. The firm has a market cap of £426.89 million, a price-to-earnings ratio of 43.54, a price-to-earnings-growth ratio of 5.00 and a beta of 0.72. The company has a quick ratio of 4.58, a current ratio of 2.79 and a debt-to-equity ratio of 31.50.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings data on Wednesday, March 18th. The company reported GBX 11.98 EPS for the quarter. Advanced Medical Solutions Group had a net margin of 4.35% and a return on equity of 3.87%. Equities research analysts predict that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.